Inclisiran treatment in high-risk patients provides sustained reductions in LDL-cholesterol: ORION-3 Medha Baranwal19 Jan 2023 9:30 AM ISTUSA: In patients with high cardiovascular risk and elevated LDL cholesterol, twice-yearly inclisiran provided early reductions in LDL cholesterol and...
Statins not warranted for healthy people with high LDL cholesterol and low triglyceride/HDL ratio Dr. Kamal Kant Kohli27 Sept 2022 11:30 AM ISTFlorida: Statins had no benefit when given to people with high LDL and optimal triglycerides and HDL. The study demonstrated "a very weak association"...
Akum Pharmaceutical gets CDSCO nod for BE study of FDC Bempedoic acid,Rosuvastatin Dr. Divya Colin8 July 2022 6:30 PM ISTNew Delhi: Pharmaceutical major, Akum Pharmaceutical has got go ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Cholesterol lowering gene changes which may increase the risk of cataracts Isra Zaman22 Jun 2022 9:00 AM ISTPeople who have genetic variations associated with lowering LDL-cholesterol similar to statin medications appear to have an increased risk of...
Cholesterol-lowering gene changes may increase risk of cataracts Dr. Kamal Kant Kohli17 Jun 2022 6:45 AM ISTDALLAS: People who have genetic variations associated with lowering LDL-cholesterol similar to statin medications appear to have an increased risk of...
Link between LDL-C lowering by statins and CVD reduction not consistent says JAMA study Dr. Kamal Kant Kohli16 March 2022 9:45 AM ISTResearchers at RCSI University of Medicine and Health Sciences have found in a new study that the link between 'bad' cholesterol (LDL-C) and poor...
Flaxseeds, almonds, avocados, tomatoes, turmeric and green tea distinctly bring down LDL cholesterol MD Bureau8 March 2022 9:15 AM ISTLifestyle management remains the foundation for the prevention of cardiovascular disease (CVD). Although LDL cholesterol is causally related to...
Orion – 4 trial: Inclisiran effective in reducing cholesterol Dr. Nandita Mohan12 Feb 2022 11:04 AM ISTInclisiran is a popular drug, studied for its effect to control bad cholesterol or LDL levels in blood, a proprotein convertase subtilisin/kexin type...
Inclisiran effective in controlling LDL Cholesterol: ORION-4 Trial MD Editorial Team5 Feb 2022 9:00 AM ISTInclisiran is a drug that reduces the amount of LDL-C in the bloodstream by improving the liver's natural ability to prevent the production of a...
No ICH risk in stroke patients with Target LDL cholesterol below 70 mg/dL: Study Medha Baranwal21 Jan 2022 9:00 AM ISTFrance: A new analysis of the TST trial reveals that targeting an LDL cholesterol of below 70 mg/dL versus 100 mg/dL in atherosclerotic ischemic...
Oral PCSK9 to drop LDL levels low Dr. Nandita Mohan6 Dec 2021 5:50 PM ISTLow-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C causes build-up of fatty deposits...
Oral PCSK9 inhibitor may significantly reduce LDL C levels: DALLAS, The First Human Trial Dr. Prem Aggarwal3 Dec 2021 2:07 PM ISTLow-density lipoprotein (LDL) cholesterol, popularly known as bad cholesterol is major cause of heart disease. LDL C causes build-up of fatty deposits...
